Annual Review

2019: THE RESTART

Scroll for more

Our
purpose

is to provide efficient and accessible
medicines through continuing
innovation and sustainable development.

Letter to the
Shareholders

The management of “Sopharma” AD is determined to re-examine the Company's strategy in the context of sustainable development. As a zero-carbon company, we turn our eyes to the broader footprint that our business and our employees leave in the environment.

Read more

Key indicators

Sopharma group

In 2019 SOPHARMA GROUP registered 8.7% growth in sales revenue

1281587

(+8.7%)

BGN '000 Revenues from sales

59692

(+52.5%)

BGN '000 Operating profit

103696

(+43.5%)

BGN '000 EBITDA

84359

(+175.4%)

BGN '000 Net profit

Sopharma AD

In 2019 we set long-term goals in the context of sustainable development and diminishing environmental footprint

230691

(+8.6%)

BGN '000 Revenues from sales

46038

(+65.6%)

BGN '000 Operating profit

64385

(+42.4%)

BGN '000 EBITDA

40382

(+21.3%)

BGN '000 Net profit

Key financial indicators
Sopharma group

BGN '000 2019 2018 2017
Revenues from sales 1 281 587 1 179 143 1 017 105
EBITDA 103 696 72 278 85 944
Operating profit 59 692 39 143 55 836
Net profit 84 359 30 637 45 772
EBITDA/ sales revenues 8.1% 6.1% 8%
Operating profit/ sales revenues 4.7% 3.3% 6%
Net debt/ EBITDA an annual basis 3.68x 4.15x 3.0x
Attracted capital/ Equity 1.04 0.99 0.95

“Sopharma” AD

BGN '000 2019 2018 2017
Revenues from sales 230 691 212 418 219 079
EBITDA 64 385 45 212 61 313
Operating profit 46 038 27 798 42 866
Net profit 40 382 33 298 44 228
EBITDA/ sales revenues 27.9% 21.3% 28%
Operating profit/ sales revenues 20.0% 13.1% 19.6%
Net debt/ EBITDA an annual basis 1.7x 1.6x 1.2x
Attracted capital/ Equity 0.30 0.24 0.24

REVENUE BREAKDOWN BY SEGMENTS IN 2019

PORTFOLIO OF PRODUCTS BY THERAPEUTIC GROUPS IN 2019

GEOGRAPHICAL SPLIT IN 2019

Environment, Social activity and Management

In order to ensure sustainable development, the Company works successfully on reducing its environmental footprint by adhering to good corporate governance practices, optimizing raw materials usage, utilizing waste, improving people's quality of life and providing excellent working conditions.

5075

EMPLOYEES IN 2018

598

DONATION IN 2018

BGN '000

5163

EMPLOYEES IN 2019

741

DONATION in 2019

BGN '000

Environment, Social activity and Management

928334

REVENUES FROM SALES OF GOODS IN 2018

BGN ‘000

250809

REVENUES FROM SALES OF PRODUCTS IN 2018

BGN ‘000

993061

REVENUES FROM SALES OF GOODS IN 2019

BGN ‘000 (+7.0%)

288526

REVENUES FROM SALES OF PRODUCTS IN 2019

BGN ‘000 (+15.0%)

Environment, Social activity and Management

9%

OF REVENUES FROM SALES OF PRODUCTS IN 2018

RAW MATERIALS

7.3%

OF REVENUES FROM SALES OF PRODUCTS IN 2019

RAW MATERIALS

MANAGEMENT TEAM

63%

Women

37%

Men

PROFILE AND
STRATEGY OF
THE COMPANY

Established pharmaceutical producer and reliable partner
with more than 85 years of history

Values
& commitment

Our values

SHORT
OVERVIEW
OF 2019

“SOPHARMA” AD
on the stock
exchange

Download
center